Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

The Competition and Markets Authority

This page shows the latest The Competition and Markets Authority news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance

AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance

The EU clearance comes after similar competition clearances in the US, Japan and other global regulatory agencies, AZ said in a statement. ... In May, the UK’s Competition and Markets Authority (CMA) announced that it was reviewing AZ’s proposed

Latest news

  • UK’s Competition and Markets Authority to review AZ/Alexion merger UK’s Competition and Markets Authority to review AZ/Alexion merger

    The UK’s Competition and Markets Authority (CMA) is set to review AstraZeneca’s (AZ) planned takeover of rare diseases specialist Alexion. ... Competition clearances have also been completed in Canada, Brazil, Russia and other countries.

  • Roche to close $4.3bn Spark deal after FTC clearance Roche to close $4.3bn Spark deal after FTC clearance

    The US antitrust approval swiftly follows the clearance from the UK’s Competition and Markets Authority (CMA), which announced early yesterday that its investigation into the merger was complete. ... However, the antitrust authority finally concluded

  • UK’s CMA clears Roche’s $4.3bn takeover of Spark UK’s CMA clears Roche’s $4.3bn takeover of Spark

    the UK's Competition and Markets Authority (CMA) finally approved the deal. . ... The CMA therefore found that the deal between Roche and Spark would not negatively affect competition because UK health services and patients will still have an adequate

  • Pfizer, Flynn face reinstatement of £90m CMA fine Pfizer, Flynn face reinstatement of £90m CMA fine

    Facing penalty for dramatic price hikes of an epilepsy drug. The UK’s competition regulator is pushing to reinstate a £90m fine for Pfizer and Flynn Pharma – quashed last year – over ... The case dates back to 2015, when the Competition and

  • Roche moving closer to approval of Spark takeover; report Roche moving closer to approval of Spark takeover; report

    Competition and Markets Authority (CMA) have taken their time to probe antitrust issued raised by the deal. ... The Capitol Forum report suggests that review staff are happy to accept the deal, but that senior officials at the FTC's Bureau of

More from news
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
foxandcat.online

some pressure is helpful but too much of the wrong sort quickly takes its toll. we help creatove agenices manage...

Latest intelligence

Virtual meeting technologies for reducing emissions and waste in the healthcare industry
...
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...

Quick links